Ann: Notice of Annual General Meeting & Voting Form, page-10

Good news, either NCCN or reimbursement and this will fly. Unfortunately the market is discounting in that one or both may not happen. The last investor presentation was encouraging however, the new CEO was bullish on both. I am hoping patience will be rewarded.

The fact that the vast majority of rejected claims are being successfully appealed is significant for me. At some point you would imagine the payors would prefer to just reimburse rather than go through the time and expense of contesting claims.

And don't forget about Heart Failure and End Stage Renal. Potential is enormous but I share fellow posters frustration at times.